Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$778 Sell
49
-162
-77% -$2.51K ﹤0.01% 319
2026
Q1
$2.85K Sell
211
-57
-21% -$798 ﹤0.01% 315
2025
Q4
$3.34K Buy
268
+41
+18% +$442 ﹤0.01% 330
2025
Q3
$2.25K Sell
227
-106
-32% -$1.03K ﹤0.01% 318
2025
Q2
$2.97K Sell
333
-3,407
-91% -$28.8K ﹤0.01% 326
2025
Q1
$32.6K Sell
3,740
-264
-7% -$2.77K ﹤0.01% 281
2024
Q4
$49.9K Sell
4,004
-326
-8% -$4.01K ﹤0.01% 286
2024
Q3
$50.3K Buy
4,330
+2,374
+121% +$27.4K ﹤0.01% 272
2024
Q2
$20.8K Buy
1,956
+1,496
+325% +$16.5K ﹤0.01% 274
2024
Q1
$5.49K Buy
+460
New +$5.54K ﹤0.01% 312

Other funds holding VTRS

BNP Paribas's VTRS Position: Q2 2026 in Review

BNP Paribas reduced its Viatris (VTRS) stake by 77% in Q2 2026, selling an estimated $2.51K and leaving 49 shares worth $778. The position accounts for ﹤0.01% of the portfolio, ranked #319.

BNP Paribas first reported a position in VTRS in Q1 2024 and has held it in 10 quarters since. The position peaked at $50.3K in Q3 2024. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • BNP Paribas held 49 shares of Viatris worth $778 as of Q2 2026.
  • BNP Paribas sold 162 Viatris shares in Q2 2026, an estimated $2.51K.
  • Viatris made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #319 holding.
  • BNP Paribas first reported a position in Viatris in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's Viatris position peaked at $50.3K in Q3 2024.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.